Drug and Alcohol Testing

DISA helps clients switch from paper to electronic Chain of Custody, streamlining drug testing, improving efficiency, and ensuring compliance.

PHMSA raises random drug testing rate from 25% to 50% for 2018 due to industry positive rates. Learn how this impacts employer compliance.

The following information reflects a combination of data collected from DISA Global Solutions’ 2017 Owners Survey, which was sent to several upstream and downstream owners.

These survey results help DISA stay on top of growing trends within the drug and alcohol testing industry, and provide clients with services that are customized to their needs.

Explore key findings from the 2017 Owner’s Report on drug testing trends, including synthetic opioids, marijuana, and workplace safety impacts.

Learn how to focus drug testing on high-risk roles to improve workplace safety, reduce liability, and enhance compliance programs.

Learn how workplace drug use impacts business costs and how DISA helps reduce risks with testing and compliance solutions.

Compare hair and urine drug testing methods to improve workplace safety, reduce risk, and strengthen your employee screening program.

Learn how the opioid crisis impacts the workplace and what employers can do to strengthen safety and drug testing policies.

See how companies like Skanska go beyond regulations with proactive safety and wellness initiatives prioritizing worker health.

DISA is committed to developing solutions to make the complex screening process easier and more efficient. The immense volume of paper required for the Chain of Custody process makes this important process slower, less accurate, and inefficient. We teamed our internal experts and technology solutions with our laboratory partner, CRL, to develop an electronic solution to eliminate the paper-heavy screening process. We also developed an electronic solution for capturing employee consent, another paper process. Now, our clients are afforded the ease and efficiency of electronic Custody and Control and electronic Consent Forms – eCCFs and eConsent.

NLCP mandates continued use of the 2014 Federal CCF as the 2017 form awaits OMB approval. Learn how this affects labs and drug testing compliance.

DISA partners with CRL and FormFox to enhance ECCF collections, improving speed, accuracy, and efficiency for clinics and employers.